The kick-off meeting of the EU project “Bicyclos,” a Staff Exchanges program under the Marie Skłodowska-Curie Actions, was a resounding success. The meeting brought together a diverse group of enthusiastic participants, each representing their respective institutions and showcasing their previous work relevant to the Bicyclos project.
Participants from various research institutions and universities across Europe gathered to discuss the exciting prospects of collaboration in cyclodextrins research. As they introduced themselves, they highlighted their affiliations and previous work that directly related to the goals of Bicyclos. The collective energy and passion in the room were palpable, underlining the participants’ eagerness to contribute to this innovative project.
The event was very well organized by the project coordinator, Ilse Manet from CNR, who ensured that all participants had a clear understanding of the project’s objectives and timeline. Her attention to detail and commitment to a smooth kickoff set a positive tone for the meeting. The extra presentations on open science and data management will also be useful for the team members.
To foster team bonding and create an enjoyable atmosphere, the participants enjoyed a delightful dinner in the inner city of Bologna. This provided an opportunity for informal discussions and further strengthened the connections among the project members.
Looking ahead, the participants eagerly anticipated the next face-to-face meeting scheduled for October 2024 in Budapest. This meeting promises to be an important milestone in the project’s progress and will provide an opportunity for more in-depth collaboration and knowledge exchange.
CarboHyde was represented by Milo Malanga, CSO, and Gergely Toth, CFO. For our company, Bicyclos presents a tremendous opportunity to advance research on cyclodextrins. The project not only facilitates the learning of their colleagues but also broadens their perspective on cyclodextrins research. It is clear that Bicyclos is not just a project but a transformative endeavor with great promise for all involved.
Team members:
CONSIGLIO NAZIONALE DELLE RICERCHE (CNR), the Coordinator
KATHOLIEKE UNIVERSITEIT LEUVEN
CarboHyde Ltd.
Consejo Superior de Investigaciones Científicas
Hacettepe Üniversitesi
Technological University Dublin
MD USE INNOVATIONS SL
CellDynamics
Eötvös Loránd Tudományegyetem
hereinafter, jointly referred to as “Beneficiaries”
University of Buenos Aires
Cyclarity Therapeutics
